TotalMarketCap

Liquidia

LQDANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.982 B

$44.49 -6.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Liquidia (LQDA) has a market capitalization of $3.98B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$158.3M

#2355 by revenue

Earnings

-$68.9M

Loss-making

Shares outstanding

89,508,891

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #58Legend BiotechLEGN$4.39B
  2. #59Edgewise TherapeuticsEWTX$4.26B
  3. #60LiquidiaLQDA$3.98B
  4. #61Xenon PharmaceuticalsXENE$3.66B
  5. #62Acadia PharmaceuticalsACAD$3.65B

What if Liquidia were worth as much as…

Open the what-if tool →

Gold $28.2T

$315,464.46

Per share 7,091× higher

Bitcoin $1.53T

$17,069.23

Per share 384× higher

Apple $5.02T

$56,036.70

Per share 1,260× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Liquidia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.